GLSI
Price
$11.85
Change
-$0.37 (-3.03%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
160.63M
77 days until earnings call
NKTR
Price
$0.81
Change
-$0.03 (-3.57%)
Updated
Mar 3, 04:59 PM (EDT)
Capitalization
154.94M
Earnings call today
Ad is loading...

GLSI vs NKTR

Header iconGLSI vs NKTR Comparison
Open Charts GLSI vs NKTRBanner chart's image
Greenwich LifeSciences
Price$11.85
Change-$0.37 (-3.03%)
Volume$500
Capitalization160.63M
Nektar Therapeutics
Price$0.81
Change-$0.03 (-3.57%)
Volume$5.36K
Capitalization154.94M
GLSI vs NKTR Comparison Chart
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. NKTR commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and NKTR is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (GLSI: $12.22 vs. NKTR: $0.84)
Brand notoriety: GLSI: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 60% vs. NKTR: 52%
Market capitalization -- GLSI: $160.63M vs. NKTR: $154.94M
GLSI [@Biotechnology] is valued at $160.63M. NKTR’s [@Biotechnology] market capitalization is $154.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, NKTR is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • GLSI’s TA Score: 3 bullish, 6 bearish.
  • NKTR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а +2.26% price change this week, while NKTR (@Biotechnology) price change was -9.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -9.54%, and the average quarterly price growth was -4.71%.

Reported Earning Dates

GLSI is expected to report earnings on May 19, 2025.

NKTR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($161M) and NKTR($155M) have the same market capitalization . GLSI YTD gains are higher at: 8.816 vs. NKTR (-9.677). GLSI has higher annual earnings (EBITDA): -10.76M vs. NKTR (-137.77M). NKTR has more cash in the bank: 244M vs. GLSI (5.82M). NKTR has higher revenues than GLSI: NKTR (93.1M) vs GLSI (0).
GLSINKTRGLSI / NKTR
Capitalization161M155M104%
EBITDA-10.76M-137.77M8%
Gain YTD8.816-9.677-91%
P/E RatioN/AN/A-
Revenue093.1M-
Total Cash5.82M244M2%
Total DebtN/A108M-
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSINKTR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAXGX16.660.25
+1.52%
Impax Global Opportunities Investor
DIGGX93.961.26
+1.36%
Invesco Discovery R5
VSCNX20.920.14
+0.67%
Natixis Vaughan Nelson Small Cap Value N
LASGX14.510.02
+0.14%
Lord Abbett International Growth R4
SUIIX53.25-0.10
-0.19%
DWS CROCI International Inst

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ORMP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+5.89%
ORMP - GLSI
35%
Loosely correlated
-0.48%
DNLI - GLSI
33%
Poorly correlated
-10.97%
ATOS - GLSI
33%
Poorly correlated
+2.78%
NKTR - GLSI
32%
Poorly correlated
+5.50%
ABOS - GLSI
32%
Poorly correlated
+1.59%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with SLS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then SLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+5.50%
SLS - NKTR
42%
Loosely correlated
+3.51%
NTLA - NKTR
39%
Loosely correlated
-7.09%
MDGL - NKTR
38%
Loosely correlated
+1.65%
IPSC - NKTR
37%
Loosely correlated
+1.53%
DNLI - NKTR
37%
Loosely correlated
-10.97%
More